focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.70
Bid: 52.00
Ask: 52.30
Change: 0.10 (0.19%)
Spread: 0.30 (0.577%)
Open: 53.00
High: 54.00
Low: 51.80
Prev. Close: 52.60
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group CEO, CIO step down after Oxford Nanopore IPO

Wed, 06th Oct 2021 09:26

(Sharecast News) - IP Group said on Wednesday that chief executive Alan Aubrey and chief investment officer Mike Townend are retiring and stepping down from the board with immediate effect following the successful flotation of its largest holding, Oxford Nanopore Technologies.
Chief financial officer Greg Smith has been promoted to the role of CEO, while chief operating officer David Baynes will become chief financial and operating officer.

IP said both Aubrey and Townend will stay on as employees until 6 April 2022 to facilitate an orderly handover and transition. They will remain as consultants for a minimum of 12 months thereafter.

Chairman Sir Douglas Flint said: "On behalf of the board and the wider IP Group family, I would like to thank both Alan and Mike for the transformational contributions they have made to IP Group over the past 16 and 14 years respectively.

"During Alan's tenure as CEO, the value of the portfolio has increased more than 28-fold to over £1.2bn and has produced several companies worth more than £1bn. We are delighted that Greg will step into the role of CEO and lead the group in its next phase. We are also pleased that Alan and Mike will continue with the group in a consulting capacity so that the group can continue to call on their significant experience in the sector.

"Greg has more than 20 years' experience in financial services, having been in the role of CFO for more than ten years and with IP Group for more than thirteen years. He has played a central role in developing and executing the group's growth strategy which made him the obvious and unanimous choice to succeed Alan."

At 0920 BST, the shares were down 5% at 129p.
More News
15 Nov 2021 14:15

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

Read more
11 Nov 2021 14:57

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

Read more
11 Nov 2021 09:18

IP Group portfolio company inks joint development agreement with Ceres Power

(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, had signed a joint development agreement with fuel cell technology firm Ceres Power.

Read more
29 Oct 2021 14:36

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

Read more
25 Oct 2021 16:10

IN BRIEF: IP Group books GBP27.5 million fair value gain

IN BRIEF: IP Group books GBP27.5 million fair value gain

Read more
25 Oct 2021 08:42

IP Group records £27.5m value gain after recent funding round

(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.

Read more
19 Oct 2021 10:50

Oxford BioMedica licences technology for cystic fibrosis treatment

Oxford BioMedica licences technology for cystic fibrosis treatment

Read more
19 Oct 2021 09:18

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology

(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.

Read more
12 Oct 2021 14:40

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

Read more
6 Oct 2021 12:11

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

Read more
6 Oct 2021 09:18

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

Read more
30 Sep 2021 12:11

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

Read more
30 Sep 2021 10:47

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

Read more
30 Sep 2021 10:42

Shares soar as Oxford Nanopore makes its London debut

(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.